Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

New England Journal of Medicine

Volumn 334, Issue 22, 1996, Pages 1422-1427

  Niederau, Claus ^a   Heintges, Tobias ^a   Lange, Stefan ^b   Goldmann, Georg ^a   Niederau, Christoph M ^a   Mohr, Leonhard ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIGEN; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; DNA, VIRAL; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2B; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0029893146     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605303342202     Document Type: Article

References (20)

1. Hoofnagle JH, Peters M, Mullen KD, et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-25.
2. Alexander GJM, Brahm J, Fagan EA, et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987;2:66-9.
3. Brook MG, McDonald JA, Karayiannis P, et al. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response. Gut 1989;130: 1116-22.
4. Saracco G, Mazzella G, Rosina F, et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989;10:336-41.
5. Perrillo RP, Schiff ER, Davis GL, et al. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990;323:295-301.
6. Perrillo RP. Antiviral therapy of chronic hepatitis B: past, present, and future. J Hepatol 1993;17:Suppl 3:S56-S63.
7. Tine F, Liberati A, Craxi A, Almasio P, Pagliaro L. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J Hepatol 1993;18:154-62.
8. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-34.
9. Carreño V, Castillo I, Molina J, Porres JC, Bartolome J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992;15:102-6.
10. Lok ASF, Chung HT, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993;105: 1833-8.
11. Perrillo RP, Brunt EM. Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen. Ann Intern Med 1991;115:113-5.
12. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
13. Realdi G, Alberti A, Rugge M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
14. Fattovich G, Rugge M, Brollo L, et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986;6:167-72.
15. Fattovich G, Brollo L, Alberti A, et al. Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatol 1990;11:29-33.
16. Niederau C, Heintges T, Niederau M, Stremmel W, Strohmeyer G. Prospective randomized controlled trial of sequential treatment with corticoids and α-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. Eur J Med 1992;1:396-402.
17. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology 1983; 3:279-84.
18. Ryff JC. To treat or not to treat? The judicious use of interferon-α-2a for the treatment of chronic hepatitis B. J Hepatol 1993;17:Suppl 3:S42-S46.
19. Brook MG, Chan G, Yap I, et al. Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection. BMJ 1989;299:652-6.
20. Niederau C, Niederau M, Stremmel W, Strohmeyer G. Therapie der chronischen Hepatitis B mit alfa-Interferon: Selektion der Patienten. In: Paumgartner G, Strohmeyer G, eds. Chronische Virushepatitis und ihre Behandlung mit Interferon alfa. Berlin, Germany: Springer-Verlag, 1991:35-45.